154
Views
49
CrossRef citations to date
0
Altmetric
Original Research

Codelivery of temozolomide and siRNA with polymeric nanocarrier for effective glioma treatment

, , , &
Pages 3467-3480 | Published online: 15 Jun 2018

References

  • WangWShiGMaBHaoXDongXZhangBChemotherapy for adults with malignant glioma: a systematic review and network meta-analysisTurk Neurosurg20172717418127337236
  • ZiuMKalkanisSNGilbertMRykenTCOlsonJJThe role of initial chemotherapy for the treatment of adults with diffuse low grade glioma: a systematic review and evidence-based clinical practice guidelineJ Neurooncol201512558560726530261
  • JuratliTASchackertGKrexDCurrent status of local therapy in malignant gliomas – a clinical review of three selected approachesPharmacol Ther201313934135823694764
  • An den BentMJBaumertBErridgeSCInterim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup studyLancet20173901645165328801186
  • PinheiroRBragaCSantosGTargeting gliomas: can a new alkylating hybrid compound make a difference?ACS Chem Neurosci20178505927665765
  • FengXZhangBWangJXuXLinNLiuHAdenovirus-mediated transfer of siRNA against basic fibroblast growth factor mRNA enhances the sensitivity of glioblastoma cells to chemotherapyMed Oncol201128243020221717
  • WhiteheadKALangerRAndersonDGKnocking down barriers: advances in sirna deliveryNat Rev Drug Discov2009812913819180106
  • JulianoRAlamMRDixitVKangHMechanisms and strategies for effective delivery of antisense and siRNA oligonucleotidesNucleic Acids Res2008364158417118558618
  • LiuXMadhankumarABSlagle-WebbBSheehanJMSurguladzeNConnorJRHeavy chain ferritin sirna delivered by cationic liposomes increases sensitivity of cancer cells to chemotherapeutic agentsCancer Res2011712240224921385903
  • Hombach-KlonischSMehrpourMShojaeiSGlioblastoma and chemoresistance to alkylating agents: involvement of apoptosis, autophagy, and unfolded protein responsePharmacol Ther2018184134129080702
  • StratenPAndersenMHThe anti-apoptotic members of the bcl-2 family are attractive tumor-associated antigensOncotarget2010123924521304176
  • SteghAHBrennanCMahoneyJAGlioma oncoprotein bcl2l12 inhibits the p53 tumor suppressorGenes Dev2010242194220420837658
  • JensenSADayESKoCHSpherical nucleic acid nanoparticle conjugates as an RNAi-based therapy for glioblastomaSci Transl Med20135209ra152
  • YuanYGongFCaoYChenWChengDShuaiXBiodegradable multiamine polymeric vector for sirna deliveryJ Biomed Nanotechnol20151166867926310073
  • YinHKanastyRLEltoukhyAAVegasAJDorkinJRAndersonDGNon-viral vectors for gene-based therapyNat Rev Genet20141554155525022906
  • IslamMAParkTESinghBMajor degradable polycations as carriers for DNA and siRNAJ Control Release2014193748924942341
  • KimJHKimYKArashMTGalactosylation of chitosan-graft-spermine as a gene carrier for hepatocyte targeting in vitro and in vivoJ Nanosci Nanotechnol2012125178518422966542
  • HongCANamYSFunctional nanostructures for effective delivery of small interfering rna therapeuticsTheranostics201441211123225285170
  • ZouSCaoNChengDEnhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of sirna and doxorubicinInt J Nanomedicine201273823383522888237
  • WeitmanSDFrazierKMKamenBAThe folate receptor in central nervous system malignancies of childhoodJ Neurooncol1994211071127861186
  • BrockmannMAPapadimitriouABrandtMInhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist nk4Clin Cancer Res200394578458514555533
  • ChengDCaoNChenJYuXShuaiXMultifunctional nanocarrier mediated co-delivery of doxorubicin and sirna for synergistic enhancement of glioma apoptosis in ratBiomaterials2012331170117922061491
  • BarthRFKaurBRat brain tumor models in experimental neuro-oncology: the c6, 9l, t9, rg2, f98, bt4c, rt-2 and cns-1 gliomasJ Neurooncol20099429931219381449
  • LathaKLiMChumbalkarVNuclear egfrviii-stat5b complex contributes to glioblastoma cell survival by direct activation of the bcl-xl promoterInt J Cancer201313250952022729867
  • ZhitaoJLongLJiaLYunchaoBAnhuaWTemozolomide sensitizes stem-like cells of glioma spheres to trail-induced apoptosis via upregulation of casitas b-lineage lymphoma (c-cbl) proteinTumour Biol2015369621963026142735
  • WakabayashiTClinical trial updates for malignant brain tumorsRinsho Shinkeigaku20115185385622277391
  • LiuXLiuCZhouJPromoting sirna delivery via enhanced cellular uptake using an arginine-decorated amphiphilic dendrimerNanoscale201573867387525283447
  • GilleronJParamasivamPZeigererAIdentification of siRNA delivery enhancers by a chemical library screenNucleic Acids Res2015437984800126220182
  • MarkmanJLRekechenetskiyAHollerELjubimovaJYNano-medicine therapeutic approaches to overcome cancer drug resistanceAdv Drug Deliv Rev2013651866187924120656
  • ButowskiNColmanHDe GrootJFOrally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy foundation early phase clinical trials consortium phase II studyNeuro Oncol20161855756426449250
  • OberoiRKParrishKESioTTMittapalliRKElmquistWFSarkariaJNStrategies to improve delivery of anticancer drugs across the blood-brain barrier to treat glioblastomaNeuro Oncol201618273626359209
  • WangSMengYLiCReceptor-mediated drug delivery systems targeting to gliomaNanomaterials (Basel)20156
  • WilhelmSTavaresAJDaiQAnalysis of nanoparticle delivery to tumoursNature2016129